Inventiva S.A. IVA
3.89 USD -0.13 (-3.12%)
Nov 12, 2026, 3:36 PM EST
3.88 Day range 4.11
2.82 52-week range 7.29
- YTD
- -16.45%
- 1 year
- -4.07%
News
benzinga.com HC Wainwright & Co. Maintains Buy on Inventiva, Lowers Price Target to $14 HC Wainwright & Co. analyst Ananda Ghosh maintains Inventiva (NASDAQ:IVA) with a Buy and lowers the price target from $24 to $14.
benzinga.com Truist Securities Maintains Buy on Inventiva, Raises Price Target to $18 Truist Securities analyst Srikripa Devarakonda maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $13 to $18.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers DataMEDS AI (NASDAQ:MEDS) stock moved upwards by 39.4% to $4.42 during Thursday's pre-market session. The company's market cap stands at $10.1 million. Stablecoin Development (AMEX:SDEV)…
benzinga.com Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session U.S. stock futures were mixed as Progress Software fell after results; Corteva, NFT, Vivakor and other stocks also dropped in premarket trading.
benzinga.com Why Vicor Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket Vicor shares surged 12% after raising Q3 growth guidance above 30%; Roze AI led gainers, while Corteva plunged 57% premarket.
benzinga.com Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On Wednesday U.S. stocks rose as Nasdaq gained 100+ points; HPE jumped 5.1% on stronger networking guidance and a Vultr AI rack order.
benzinga.com Canaccord Genuity Maintains Buy on Inventiva, Raises Price Target to $21 Canaccord Genuity analyst Edward Nash maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $20 to $21.
benzinga.com Vail Resorts, Inventiva And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session U.S. futures mixed as Vail Resorts fell after a Q4 loss miss despite beating sales estimates; several stocks also declined premarket.- benzinga.com Inventiva H1 2026 Earnings Call: Complete Transcript On Monday, Inventiva (NASDAQ:IVA) discussed quarterly financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive…
benzinga.com Earnings Scheduled For September 28, 2026 Companies Reporting Before The Bell • Kandi Technologies Gr (NASDAQ:KNDI) is likely to report earnings for its first quarter. • Inventiva (NASDAQ:IVA) is expected to report quarterly loss at $0.20…- benzinga.com Inventiva H1 EPS $(0.29) Misses $(0.20) Estimate, Sales $23.251K Miss $10.000M Estimate Inventiva (NASDAQ:IVA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.20) by 45 percent. This is a 84.24 percent increase over losses of $(1.84) per…
- benzinga.com Earnings Scheduled For September 25, 2026 Companies Reporting Before The Bell • Tamboran Resources (NYSE:TBN) is estimated to report quarterly loss at $0.30 per share on revenue of $3.82 million. Companies Reporting After The Bell •…
benzinga.com Novo Nordisk, Telix Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session U.S. futures rose, but Novo Nordisk fell 4.8% after Cagrisema trial results; Aligos, Telix and other stocks also dropped premarket.
benzinga.com Guggenheim Maintains Buy on Inventiva, Raises Price Target to $14 Guggenheim analyst Seamus Fernandez maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $11 to $14.
benzinga.com Inventiva Completes Final 72-Week NATiV3 Patient Visit With 1,419 Patients Enrolled, Topline Results Expected Q4 2026 Last patient completed final 72-week visit in NATiV3, with 1,009 patients enrolled in the main cohort and 410 patients in the exploratory cohortTopline results of NATiV3 expected in Q4 2026September…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Intelligent Bio Solutions (NASDAQ:INBS) stock moved upwards by 8.2% to $2.63 during Tuesday's after-market session. The company's market cap stands at $7.2 million. Jaguar Health…
benzinga.com Pinterest, Destiny Tech100 And Other Big Stocks Moving Lower In Monday’s Pre-Market Session U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Monday. Shares of Pinterest, Inc. (NYSE:PINS) fell sharply in pre-market trading following the announcement…- benzinga.com Inventiva Reports No Revenue During H1, Compared To €4.5M YoY Inventiva (Euronext Paris and NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic
benzinga.com Kura Sushi Posts Weak Q3 Sales, Joins FuelCell Energy And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session US stock futures lower with Dow down 500 points. Kura Sushi shares drop after reporting worse-than-expected sales. Other stocks also decline in pre-market.- benzinga.com Inventiva Secures €43M Investment for Liver Disease Drug, Supports Phase 3 MASH Treatment Trial Europe's largest independent growth debt fund manager has made an investment through its funds, of €43m in Inventiva (NASDAQ:IVA), a clinical-stage biopharmaceutical company developing an oral…
benzinga.com Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session US stock futures lower, Nasdaq down 1%. Super Micro shares down 8.6% after announcing $7B offering to fund AI orders. Other stocks also down in pre-market trading.
benzinga.com Inventiva Enters Comprehensive Refinancing Agreements, Comprising Repayment Of The Existing EIB Loan And Partial Warrant Buyback Of Those Issued The EIB; Shares Resume Rrading On Euronext Paris Secured a new debt financing with funds and accounts managed by BlackRock and Claret Capital Partners, respectively for up to €130 million in committed tranches, subject to conditions, plus an…- benzinga.com Inventiva Halts Paris Trading Ahead of Planned Financing Announcement, Shares Expected to Resume Trading Later Tuesday Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated…
benzinga.com Phreesia, Service Properties Trust, Inventiva And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session U.S. stock futures rise on Tuesday with Dow futures up 400 points. Phreesia shares fall 26.5% in pre-market after mixed Q4 results and lower sales guidance. Other stocks also decline.
benzinga.com Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its second SpaceShip is expected to enter service soon, causing a 6% jump in pre-market trading. Other…- benzinga.com Inventiva FY EPS $(2.14) Misses $(1.66) Estimate, Sales $5.064M Miss $6.000M Estimate Inventiva (NASDAQ:IVA) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(1.66) by 28.92 percent. This is a 35.74 percent increase over losses of $(3.33)…
- benzinga.com Earnings Scheduled For March 30, 2026
benzinga.com Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of public offerings. Other stocks also lower.
benzinga.com Why Newsmax Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket Newsmax Inc (NMAX) shares rose on better-than-expected Q4 results & FY26 sales guidance. Pre-market gainers include ONCO, VSA, GMEX, IZM, GVH, BATL, U, SGML, & GLND. Losers are SLND, DTCX, TOP, SVRN,…
benzinga.com This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday Wall Street analysts changed outlook on top names. Clear Street initiated coverage on RKLB with Buy rating, $88 PT. See analyst ratings.- benzinga.com Truist Securities Initiates Coverage On Inventiva with Buy Rating, Announces Price Target of $13 Truist Securities analyst Srikripa Devarakonda initiates coverage on Inventiva (NASDAQ:IVA) with a Buy rating and announces Price Target of $13.
benzinga.com Barclays Initiates Coverage On Inventiva with Overweight Rating, Announces Price Target of $18 Barclays analyst Eliana Merle initiates coverage on Inventiva (NASDAQ:IVA) with a Overweight rating and announces Price Target of $18.
benzinga.com Leerink Partners Initiates Coverage On Inventiva with Outperform Rating, Announces Price Target of $12 Leerink Partners analyst Thomas Smith initiates coverage on Inventiva (NASDAQ:IVA) with a Outperform rating and announces Price Target of $12.
benzinga.com Tilray Brands, SuperX AI Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session 
benzinga.com Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket 
benzinga.com Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session 
benzinga.com Why LexinFintech Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - benzinga.com Guggenheim Maintains Buy on Inventiva, Lowers Price Target to $11 Guggenheim analyst Seamus Fernandez maintains Inventiva (NASDAQ:IVA) with a Buy and lowers the price target from $13 to $11.
- benzinga.com Inventiva Announced That The Underwriters Of The Previously Announced Public Offering Have Exercised In Full Their Option To Purchase 5.84M Additional American Depositary Shares Following the exercise in full of the Underwriters' Option, the total number of ADSs issued in the Offering will amount to 44,805,193, resulting in gross proceeds for the Company of approximately…
- benzinga.com Inventiva Prices U.S. Offering Of 38.96M ADSs At $3.85 Each; Settlement Expected November 17 Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic…
- benzinga.com Inventiva Plans To Launch $125M American Depositary Shares Offering Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic…
- benzinga.com Wolfe Research Initiates Coverage On Inventiva with Outperform Rating, Announces Price Target of $13 Wolfe Research analyst Steve Fleishman initiates coverage on Inventiva (NASDAQ:IVA) with a Outperform rating and announces Price Target of $13.
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session 
benzinga.com Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Tesla, IBM, Molina Healthcare And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Satellogic, Hewlett Packard Enterprise, Bitfarms And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session